tirzepatide compound fda lawsuit confirms shortage is still over, gives compounders a grace period FDA ban on compounded tirzepatide:

This finding highlights a neuron-independent pathway through which immune cells can directly regulate motility within the muscularis

Are you considering fat dissolving injections as a solution for your stubborn fat deposits

Across all three Tirzepatide doses (5mg, 10mg, 15mg), HbA1c reduction was superior to semaglutide, with the 15mg dose producing a mean HbA1c reduction of 2.46% versus 1.86% for semaglutide

Administrative Reconsideration : While the Trump administration chose not to implement the coverage change in 2025, they did not rule out reconsidering the policy in the future as more data becomes available on both costs and benefits